SOPHiA GENETICS SA Receivables 2020-2024 | SOPH

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

SOPHiA GENETICS SA receivables from 2020 to 2024. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

SOPHiA GENETICS SA receivables from 2020 to 2024. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
GE HealthCare Technologies (GEHC)	$40.4B
Tempus AI (TEM)	$7.9B
Inspire Medical Systems (INSP)	$6.2B
Axonics (AXNX)	$3.5B
Hims & Hers Health (HIMS)	$3.5B
10x Genomics (TXG)	$2.7B
Enovis (ENOV)	$2.4B
Azenta (AZTA)	$2.4B
Privia Health (PRVA)	$2.3B
IRhythm Technologies (IRTC)	$2.2B
Omnicell (OMCL)	$2B
Clover Health Investments (CLOV)	$1.5B
Schrodinger (SDGR)	$1.4B
Phreesia (PHR)	$1.4B
Standard BioTools (LAB)	$753M
Fulgent Genetics (FLGT)	$694M
Definitive Healthcare (DH)	$538M
Health Catalyst (HCAT)	$529M
Butterfly Network (BFLY)	$406M
Talkspace (TALK)	$343M
Pulmonx (LUNG)	$329M
TruBridge (TBRG)	$183M
P3 Health Partners (PIII)	$165M
American Well (AMWL)	$147M
Augmedix (AUGX)	$115M
EUDA Health Holdings (EUDA)	$90M
Future Health ESG (FHLT)	$65M
SHL Telemedicine (SHLT)	$55M
HeartBeam (BEAT)	$53M
111 (YI)	$51M